IPO Date: January 1967Market Cap: $253 million Siebert made history when she became the first woman to own a seat on the New York Stock Exchange in 1967, after her application was rejected nine times. Siebert passed away in 2013. Since then, the financial services firm was acquired by Kennedy Cabot Acquisition in 2016 and expanded its offerings to include insurance services and portfolio management. IPO Date: May 5, 1999Market Cap: $79 millionHughes became the first Black woman to lead a publicly-traded corporation when media company Urban One went public in 1999. Today, the founder and chairperson leads the largest Black-owned and operated broadcast company in the US, operating 55 radio stations. IPO Date: August 14, 2007Market Cap: $58 billion Diane Greene was one of the cofounders of VMWare in 1998, and the company was sold to EMC (later Dell EMC) in 2004, and then went public with Greene at the helm. After she left VMWare in 2008, Greene went on to become CEO of Google Cloud from 2015-2019, and has served on the board for such companies as Intuit, Alphabet, and Stripe.Currently Greene is a Chairman of the Corporation at one of her alma mater, the Massachusetts Instutute of Technology. IPO Date: August 2, 2013 Market Cap: $277 million Founded in 2006, Marrone Bio Innovations is a pest management and plant health product company. The company employs over 100 workers. Pamela Marrone retired as CEO of Marrone Bio Innovations in August 2020. Today, she advises startups and serves as executive chairperson and partner of bioagricultural companies Primary BioAg Innovations and Global BioAg Linkages. Marrone received the title of The Most Admired CEO, Distinguished Career Award by the Sacramento Business Journal in 2020. IPO Date: October 30, 2013 Market Cap: $3 billion Founded in 2008 by Anderson and Douglas Dolginow, Veracyte is a healthcare company that provides genomic diagnostics for oncology patients. The San Fransisco-based company has more than 350 employees. Before cofounding Veracyte, Anderson served as a strategic consultant for early-stage businesses. IPO Date: January 10, 2014 Market Cap: $173 million GlycoMimetics is a biotechnology company focused on oncology. Before founding GlycoMimetics, King worked in leadership positions at Novartis and Genetic Therapy. She led Genetic Therapy's IPO and eventual acquisition by Novartis. King holds an MBA from Harvard Business School and served as chair of the Maryland Life Sciences Advisory Board under former Governor Martin O'Malley.King cofounded the company with John Magnani.IPO Date: January 24, 2014 Valuation: $500 million*Marcelo founded Care.com in 2006 as a way to address a problem she herself had faced as a working mother: finding care for her children as she worked a full-time job. The website offers services that connect families with caregivers. Care.com now has over 35 million members in over 20 countries. The company was acquired by holding company IAC in February 2020 for $500 million. *Care.com was a publicly-traded company when tracking for this list first began. Shortly after, it was acquired by IAC for $500 million.IPO Date: May 13, 2015 Market Cap: $237 million Jaguar Health is a pharmaceutical company that works to develop and commercialize plant-based prescription medicines. Conte has worked in plant-based prescription medicine development for over 30 years, and holds an M.S. in physiology and pharmacology from the University of California, San Diego, and an MBA and a bachelor's degree in biochemistry from Dartmouth College.IPO Date: August 5, 2015 Market cap: $14 billion Sunrun is a San Fransisco-based home solar power company cofounded by Jurich and Ed Fenster. As CEO, Jurich has worked to install more than $3 billion worth of solar systems across 22 states, Puerto Rico, and the District of Columbia. Jurich was named one of Forbes' Women to Watch in 2015, and is also an angel investor. IPO Date: February 2, 2016Market Cap: $4.5 billion Editas Medicine is a clinical-stage biotechnology company focused on using genome editing to develop new medicines. Doudna received a Nobel Prize in chemistry in 2020 for discovering the genome-editing tool CRISPR-Cas-9 in 2012 together with Emmanuelle Charpentier, a researcher and professor in microbiology, marking the first time two women have won a Nobel Prize in science. IPO Date: June 29, 2016 Market Cap: $83 millionCatabasis Pharmaceuticals was founded in 2008 as a clinical-stage pharmaceutical company focusing on therapeutic treatments for rare diseases. Before cofounding Catabasis with Michael Jirousek, Milne led drug development at companies like Srtris Pharmaceuticals and Pfizer. IPO Date: October 27, 2016 Market Cap: $8 billionBlackLine is an enterprise software company developing cloud-based services for accounting and finance. The company has a market cap of over $7 billion.Tucker launched BlackLine in 2001. Before founding the company, she worked in financial accounting and technology development for more than 25 years. IPO Date: November 17, 2017 Market Cap: $8.7 billion Stitch Fix is a personal shopping company that provides algorithmic-supported styling options for its clients. In 2017, Lake, who worked at the intersection of fashion, retail, and technology, became the youngest female founder to take a company public at 34. She founded the company in 2011, at age 18. Today the company is valued at over $2 billion. IPO Date: September 30, 2018 Market Cap: $2 billion Global event management and ticketing site Eventbrite made one of the biggest opening-day debuts when it went public in 2018, raising $230 million.The company has received praise for its positive office environment, and Hartz was named one of Fortune's 40 Under 40 business leaders in 2015. She cofounded the company with Renaud Visage and Kevin Hartz.IPO Date: October 30, 2018 Market Cap: $8 billionTwist Bioscience manufactures synthetic DNA. Leproust cofounded the company with Bill Peck in 2013, and was named one of Foreign Policy's 100 Leading Global Thinkers in 2015 for her work accelerating DNA manufacturing and production. IPO Date: May 8, 2019 Market Cap: $1 billion Cortexyme works on creating therapeutic solutions for patients diagnosed with Alzheimer's and other degenerative diseases. Before cofounding Cortexyme, Lynch led various companies in the biotech space, including Aspira Biosystems and Neuronsights. She also sits on the board of directors of the California Life Science Association. IPO Date: May 31, 2019 Market Cap: $2 billion TheRealReal founder and CEO Julia Wainright founded the luxury consignment store in 2011 out of her home after working with various start ups and leading online video site Reel.com and serving as CEO of Pets.com. Today, the company has over 7 million subscribers and four retail stores across the country. IPO Date: September 18, 2020 Market Cap: $774 millionKawas was the first woman to guide a company through an IPO in Washington State in more than 20 years. Her pharmaceutical company, Athira, develops therapeutics to treat Alzheimer's and other diseases. Athira raised $204 million in its initial IPO. IPO Date: September 25, 2020 Market Cap: $110 millionAmesite is a Michigan-based artificial intelligence software company that works to improve learning outcomes. In 2020, Amesite received a Business Innovation Intelligence Group award for generating new ideas. Sastry founded the company in 2017 after cofounding battery company Sakti3, which was acquired by Dyson for $90 million in 2015. Expected IPO Date: February 11, 2021Valuation: $6 billionOn January 15, female-centered dating app Bumble filed for an IPO. The company plans to go public in mid-February. Bumble, which was created in 2014, was born out of Herd's idea to create a social network designed around women, which eventually grew into a dating app where women had the power to make the first move on matches.The idea took off. As of September 2020, Bumble has more than 42 million active users. The majority of Bumble's board is composed of women, and Wolfe Herd, 31, will be the youngest female CEO to take her company public when the IPO is complete.